Global Absorbable Hemostat Market Growth 2024-2030

Absorbable Hemostat: Valued at US$ 21.47 billion in 2023, projected to reach US$ 31.45 billion by 2030, with a 5.6% CAGR, fueled by increasing demand in the downstream market.

According to Publisher’s latest study, the global Absorbable Hemostat market size was valued at US$ 21470 million in 2023. With the growing demand in the downstream market, the Absorbable Hemostat is forecast to have a readjusted size of US$ 31450 million by 2030 with a CAGR of 5.6% during the review period.

Market Overview

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The research report highlights the growth potential of the global Absorbable Hemostat market. Absorbable Hemostats are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Absorbable Hemostat. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Absorbable Hemostat market. Absorbable hemostatic material is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period.

Key Features:

The report on the Absorbable Hemostat market reflects various aspects and provides valuable insights into the industry.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Market Drivers: Chronic Disease Prevalence: The rise in chronic illnesses drives the need for surgical procedures, which increases the market for absorbable hemostats. By helping to control bleeding issues during procedures, these hemostatic medicines improve patient outcomes.

Minimally Invasive Surgery: As these procedures become more common, there is a growing need for absorbable hemostats that work well with them. The market is growing because hemostatic agents that guarantee quick hemostasis and less tissue damage are chosen.

Ageing Population: Especially among the elderly, the ageing global population is a factor in the rising need for surgical treatments. This market is growing because absorbable hemostats are essential for controlling bleeding issues in this population.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval


Challenges- Regulatory Compliance: Manufacturers face difficulties in getting clearance and meeting strict regulations. Time-to-market and expenses are increased by the need for lengthy clinical trials and documentation to comply with safety, effectiveness, and quality standards.

Cost Restrictions: Reimbursement issues and price sensitivity among healthcare providers prevent the market from expanding. Adoption may be hampered by absorbable hemostats' expensive price, particularly in healthcare settings where money is tight.

Competition from Alternatives: There are difficulties when dealing with competition from topical medications and mechanical hemostats, two types of alternative hemostatic treatments. To be competitive, market competitors need to set their products apart concerning their efficacy, safety, and convenience of use.

Market Forecasts and Future Outlook: Technological Innovation: Ongoing R&D expenditures to create cutting-edge hemostatic technology and meet unmet clinical requirements. Market Expansion: To take advantage of the rising demand for absorbable hemostats, enter emerging markets and form strategic alliances. Affordable Solutions: Creating affordable absorbable hemostats to increase accessibility is important, especially in healthcare settings with limited resources.

Opportunities: Technological Advancements: Market participants have the chance to innovate and launch cutting-edge hemostatic technologies by continuing to invest in research and development. The effectiveness and adaptability of absorbable hemostats can be improved by the development of innovative biomaterials, tailored delivery methods, and combination therapies, meeting a range of surgical requirements and increasing market potential.

Market Expansion: Opportunities for expansion and market diversification arise from entering emerging markets, especially those in Asia-Pacific and Latin America. A climate that is favourable for market penetration and expansion is produced in these locations by rising investments in healthcare infrastructure, a rise in surgery volumes, and improved access to healthcare services.

Market Segmentation:

The Absorbable Hemostat market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. In terms of product, gauze is the largest segment, with a share of over 40%. In terms of application, the largest application is hospitals, followed by clinics, etc.

1. Segmentation by type
• Gauze
• Powder
• Gelatin Sponge
• Other
2. Segmentation by application
• Hospital
• Clinics
• Other

Regional Insights: America: Leading the world's absorbable hemostat market, America is dominated by major players and has a sophisticated healthcare infrastructure. Market expansion is facilitated by advantageous reimbursement policies and technological improvements. Europe: Due to strict regulatory requirements and a growing uptake of cutting-edge surgical methods, Europe is a sizable market. The UK and Germany are two important nations that support market expansion. Asia-Pacific: Growing surgical volumes and an expanding healthcare infrastructure are driving the region's fast market expansion. Paying chances for market expansion are abundant in emerging markets such as China and India. Europe is the largest production market, with a share of over 35%, followed by North America, and Japan, the total has a share of about 40 per cent.

1. Americas
• United States
• Canada
• Mexico
• Brazil
2. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
3. Europe
• Germany
• France
• UK
• Italy
• Russia
4. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape- Global absorbable hemostatic key players include Curasan AG, Johnson & Johnson, Cura Medical, GELITA MEDICAL, B.Braun, etc. Global top five manufacturers hold a production share of over 35%. The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, and market penetration.
• Johnson & Johnson
• BD
• Baxter
• B.Braun
• Cura Medical
• GELITA MEDICAL
• Curasan AG
• Meril Life Sciences
• Zhonghui Shengxi
• Beijing Datsing Biotech
• Guizhou Jin Jiu Biotech
• Beijing Taikesiman
• Foryou Medical
• Saikesaisi Holdings Group
• Biotemed

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Absorbable Hemostat Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Absorbable Hemostat by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Absorbable Hemostat by Country/Region, 2019, 2023 & 2030
  • 2.2 Absorbable Hemostat Segment by Type
  • 2.2.1 Gauze
  • 2.2.2 Powder
  • 2.2.3 Gelatin Sponge
  • 2.2.4 Other
  • 2.3 Absorbable Hemostat Sales by Type
  • 2.3.1 Global Absorbable Hemostat Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Absorbable Hemostat Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Absorbable Hemostat Sale Price by Type (2019-2024)
  • 2.4 Absorbable Hemostat Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Clinics
  • 2.4.3 Other
  • 2.5 Absorbable Hemostat Sales by Application
  • 2.5.1 Global Absorbable Hemostat Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Absorbable Hemostat Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Absorbable Hemostat Sale Price by Application (2019-2024)
  • 3 Global Absorbable Hemostat by Company
  • 3.1 Global Absorbable Hemostat Breakdown Data by Company
  • 3.1.1 Global Absorbable Hemostat Annual Sales by Company (2019-2024)
  • 3.1.2 Global Absorbable Hemostat Sales Market Share by Company (2019-2024)
  • 3.2 Global Absorbable Hemostat Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Absorbable Hemostat Revenue by Company (2019-2024)
  • 3.2.2 Global Absorbable Hemostat Revenue Market Share by Company (2019-2024)
  • 3.3 Global Absorbable Hemostat Sale Price by Company
  • 3.4 Key Manufacturers Absorbable Hemostat Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Absorbable Hemostat Product Location Distribution
  • 3.4.2 Players Absorbable Hemostat Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Absorbable Hemostat by Geographic Region
  • 4.1 World Historic Absorbable Hemostat Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Absorbable Hemostat Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Absorbable Hemostat Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Absorbable Hemostat Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Absorbable Hemostat Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Absorbable Hemostat Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Absorbable Hemostat Sales Growth
  • 4.4 APAC Absorbable Hemostat Sales Growth
  • 4.5 Europe Absorbable Hemostat Sales Growth
  • 4.6 Middle East & Africa Absorbable Hemostat Sales Growth
  • 5 Americas
  • 5.1 Americas Absorbable Hemostat Sales by Country
  • 5.1.1 Americas Absorbable Hemostat Sales by Country (2019-2024)
  • 5.1.2 Americas Absorbable Hemostat Revenue by Country (2019-2024)
  • 5.2 Americas Absorbable Hemostat Sales by Type
  • 5.3 Americas Absorbable Hemostat Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Absorbable Hemostat Sales by Region
  • 6.1.1 APAC Absorbable Hemostat Sales by Region (2019-2024)
  • 6.1.2 APAC Absorbable Hemostat Revenue by Region (2019-2024)
  • 6.2 APAC Absorbable Hemostat Sales by Type
  • 6.3 APAC Absorbable Hemostat Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Absorbable Hemostat by Country
  • 7.1.1 Europe Absorbable Hemostat Sales by Country (2019-2024)
  • 7.1.2 Europe Absorbable Hemostat Revenue by Country (2019-2024)
  • 7.2 Europe Absorbable Hemostat Sales by Type
  • 7.3 Europe Absorbable Hemostat Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Absorbable Hemostat by Country
  • 8.1.1 Middle East & Africa Absorbable Hemostat Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Absorbable Hemostat Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Absorbable Hemostat Sales by Type
  • 8.3 Middle East & Africa Absorbable Hemostat Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Absorbable Hemostat
  • 10.3 Manufacturing Process Analysis of Absorbable Hemostat
  • 10.4 Industry Chain Structure of Absorbable Hemostat
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Absorbable Hemostat Distributors
  • 11.3 Absorbable Hemostat Customer
  • 12 World Forecast Review for Absorbable Hemostat by Geographic Region
  • 12.1 Global Absorbable Hemostat Market Size Forecast by Region
  • 12.1.1 Global Absorbable Hemostat Forecast by Region (2025-2030)
  • 12.1.2 Global Absorbable Hemostat Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Absorbable Hemostat Forecast by Type
  • 12.7 Global Absorbable Hemostat Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Johnson & Johnson
  • 13.1.1 Johnson & Johnson Company Information
  • 13.1.2 Johnson & Johnson Absorbable Hemostat Product Portfolios and Specifications
  • 13.1.3 Johnson & Johnson Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Johnson & Johnson Main Business Overview
  • 13.1.5 Johnson & Johnson Latest Developments
  • 13.2 BD
  • 13.2.1 BD Company Information
  • 13.2.2 BD Absorbable Hemostat Product Portfolios and Specifications
  • 13.2.3 BD Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 BD Main Business Overview
  • 13.2.5 BD Latest Developments
  • 13.3 Baxter
  • 13.3.1 Baxter Company Information
  • 13.3.2 Baxter Absorbable Hemostat Product Portfolios and Specifications
  • 13.3.3 Baxter Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Baxter Main Business Overview
  • 13.3.5 Baxter Latest Developments
  • 13.4 B.Braun
  • 13.4.1 B.Braun Company Information
  • 13.4.2 B.Braun Absorbable Hemostat Product Portfolios and Specifications
  • 13.4.3 B.Braun Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 B.Braun Main Business Overview
  • 13.4.5 B.Braun Latest Developments
  • 13.5 Cura Medical
  • 13.5.1 Cura Medical Company Information
  • 13.5.2 Cura Medical Absorbable Hemostat Product Portfolios and Specifications
  • 13.5.3 Cura Medical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Cura Medical Main Business Overview
  • 13.5.5 Cura Medical Latest Developments
  • 13.6 GELITA MEDICAL
  • 13.6.1 GELITA MEDICAL Company Information
  • 13.6.2 GELITA MEDICAL Absorbable Hemostat Product Portfolios and Specifications
  • 13.6.3 GELITA MEDICAL Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 GELITA MEDICAL Main Business Overview
  • 13.6.5 GELITA MEDICAL Latest Developments
  • 13.7 Curasan AG
  • 13.7.1 Curasan AG Company Information
  • 13.7.2 Curasan AG Absorbable Hemostat Product Portfolios and Specifications
  • 13.7.3 Curasan AG Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Curasan AG Main Business Overview
  • 13.7.5 Curasan AG Latest Developments
  • 13.8 Meril Life Sciences
  • 13.8.1 Meril Life Sciences Company Information
  • 13.8.2 Meril Life Sciences Absorbable Hemostat Product Portfolios and Specifications
  • 13.8.3 Meril Life Sciences Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Meril Life Sciences Main Business Overview
  • 13.8.5 Meril Life Sciences Latest Developments
  • 13.9 Zhonghui Shengxi
  • 13.9.1 Zhonghui Shengxi Company Information
  • 13.9.2 Zhonghui Shengxi Absorbable Hemostat Product Portfolios and Specifications
  • 13.9.3 Zhonghui Shengxi Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Zhonghui Shengxi Main Business Overview
  • 13.9.5 Zhonghui Shengxi Latest Developments
  • 13.10 Beijing Datsing Bio-tech
  • 13.10.1 Beijing Datsing Bio-tech Company Information
  • 13.10.2 Beijing Datsing Bio-tech Absorbable Hemostat Product Portfolios and Specifications
  • 13.10.3 Beijing Datsing Bio-tech Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Beijing Datsing Bio-tech Main Business Overview
  • 13.10.5 Beijing Datsing Bio-tech Latest Developments
  • 13.11 Guizhou Jin Jiu Biotech
  • 13.11.1 Guizhou Jin Jiu Biotech Company Information
  • 13.11.2 Guizhou Jin Jiu Biotech Absorbable Hemostat Product Portfolios and Specifications
  • 13.11.3 Guizhou Jin Jiu Biotech Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Guizhou Jin Jiu Biotech Main Business Overview
  • 13.11.5 Guizhou Jin Jiu Biotech Latest Developments
  • 13.12 Beijing Taikesiman
  • 13.12.1 Beijing Taikesiman Company Information
  • 13.12.2 Beijing Taikesiman Absorbable Hemostat Product Portfolios and Specifications
  • 13.12.3 Beijing Taikesiman Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 Beijing Taikesiman Main Business Overview
  • 13.12.5 Beijing Taikesiman Latest Developments
  • 13.13 Foryou Medical
  • 13.13.1 Foryou Medical Company Information
  • 13.13.2 Foryou Medical Absorbable Hemostat Product Portfolios and Specifications
  • 13.13.3 Foryou Medical Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 Foryou Medical Main Business Overview
  • 13.13.5 Foryou Medical Latest Developments
  • 13.14 Saikesaisi Holdings Group
  • 13.14.1 Saikesaisi Holdings Group Company Information
  • 13.14.2 Saikesaisi Holdings Group Absorbable Hemostat Product Portfolios and Specifications
  • 13.14.3 Saikesaisi Holdings Group Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.14.4 Saikesaisi Holdings Group Main Business Overview
  • 13.14.5 Saikesaisi Holdings Group Latest Developments
  • 13.15 Biotemed
  • 13.15.1 Biotemed Company Information
  • 13.15.2 Biotemed Absorbable Hemostat Product Portfolios and Specifications
  • 13.15.3 Biotemed Absorbable Hemostat Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.15.4 Biotemed Main Business Overview
  • 13.15.5 Biotemed Latest Developments
  • 14 Research Findings and Conclusion

List of Tables
Table 1. Absorbable Hemostat Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Absorbable Hemostat Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gauze
Table 4. Major Players of Powder
Table 5. Major Players of Gelatin Sponge
Table 6. Major Players of Other
Table 7. Global Absorbable Hemostat Sales by Type (2019-2024) & (K Units)
Table 8. Global Absorbable Hemostat Sales Market Share by Type (2019-2024)
Table 9. Global Absorbable Hemostat Revenue by Type (2019-2024) & ($ million)
Table 10. Global Absorbable Hemostat Revenue Market Share by Type (2019-2024)
Table 11. Global Absorbable Hemostat Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Absorbable Hemostat Sales by Application (2019-2024) & (K Units)
Table 13. Global Absorbable Hemostat Sales Market Share by Application (2019-2024)
Table 14. Global Absorbable Hemostat Revenue by Application (2019-2024)
Table 15. Global Absorbable Hemostat Revenue Market Share by Application (2019-2024)
Table 16. Global Absorbable Hemostat Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Absorbable Hemostat Sales by Company (2019-2024) & (K Units)
Table 18. Global Absorbable Hemostat Sales Market Share by Company (2019-2024)
Table 19. Global Absorbable Hemostat Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Absorbable Hemostat Revenue Market Share by Company (2019-2024)
Table 21. Global Absorbable Hemostat Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Absorbable Hemostat Producing Area Distribution and Sales Area
Table 23. Players Absorbable Hemostat Products Offered
Table 24. Absorbable Hemostat Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Absorbable Hemostat Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Absorbable Hemostat Sales Market Share Geographic Region (2019-2024)
Table 29. Global Absorbable Hemostat Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Absorbable Hemostat Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Absorbable Hemostat Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Absorbable Hemostat Sales Market Share by Country/Region (2019-2024)
Table 33. Global Absorbable Hemostat Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Absorbable Hemostat Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Absorbable Hemostat Sales by Country (2019-2024) & (K Units)
Table 36. Americas Absorbable Hemostat Sales Market Share by Country (2019-2024)
Table 37. Americas Absorbable Hemostat Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Absorbable Hemostat Revenue Market Share by Country (2019-2024)
Table 39. Americas Absorbable Hemostat Sales by Type (2019-2024) & (K Units)
Table 40. Americas Absorbable Hemostat Sales by Application (2019-2024) & (K Units)
Table 41. APAC Absorbable Hemostat Sales by Region (2019-2024) & (K Units)
Table 42. APAC Absorbable Hemostat Sales Market Share by Region (2019-2024)
Table 43. APAC Absorbable Hemostat Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Absorbable Hemostat Revenue Market Share by Region (2019-2024)
Table 45. APAC Absorbable Hemostat Sales by Type (2019-2024) & (K Units)
Table 46. APAC Absorbable Hemostat Sales by Application (2019-2024) & (K Units)
Table 47. Europe Absorbable Hemostat Sales by Country (2019-2024) & (K Units)
Table 48. Europe Absorbable Hemostat Sales Market Share by Country (2019-2024)
Table 49. Europe Absorbable Hemostat Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Absorbable Hemostat Revenue Market Share by Country (2019-2024)
Table 51. Europe Absorbable Hemostat Sales by Type (2019-2024) & (K Units)
Table 52. Europe Absorbable Hemostat Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Absorbable Hemostat Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Absorbable Hemostat Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Absorbable Hemostat Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Absorbable Hemostat Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Absorbable Hemostat Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Absorbable Hemostat Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Absorbable Hemostat
Table 60. Key Market Challenges & Risks of Absorbable Hemostat
Table 61. Key Industry Trends of Absorbable Hemostat
Table 62. Absorbable Hemostat Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Absorbable Hemostat Distributors List
Table 65. Absorbable Hemostat Customer List
Table 66. Global Absorbable Hemostat Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Absorbable Hemostat Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Absorbable Hemostat Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Absorbable Hemostat Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Absorbable Hemostat Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Absorbable Hemostat Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Absorbable Hemostat Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Absorbable Hemostat Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Absorbable Hemostat Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Absorbable Hemostat Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Absorbable Hemostat Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Absorbable Hemostat Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Absorbable Hemostat Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Absorbable Hemostat Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Johnson & Johnson Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson Absorbable Hemostat Product Portfolios and Specifications
Table 82. Johnson & Johnson Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. BD Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 86. BD Absorbable Hemostat Product Portfolios and Specifications
Table 87. BD Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. BD Main Business
Table 89. BD Latest Developments
Table 90. Baxter Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 91. Baxter Absorbable Hemostat Product Portfolios and Specifications
Table 92. Baxter Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Baxter Main Business
Table 94. Baxter Latest Developments
Table 95. B.Braun Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 96. B.Braun Absorbable Hemostat Product Portfolios and Specifications
Table 97. B.Braun Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. B.Braun Main Business
Table 99. B.Braun Latest Developments
Table 100. Cura Medical Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 101. Cura Medical Absorbable Hemostat Product Portfolios and Specifications
Table 102. Cura Medical Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cura Medical Main Business
Table 104. Cura Medical Latest Developments
Table 105. GELITA MEDICAL Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 106. GELITA MEDICAL Absorbable Hemostat Product Portfolios and Specifications
Table 107. GELITA MEDICAL Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. GELITA MEDICAL Main Business
Table 109. GELITA MEDICAL Latest Developments
Table 110. Curasan AG Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 111. Curasan AG Absorbable Hemostat Product Portfolios and Specifications
Table 112. Curasan AG Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Curasan AG Main Business
Table 114. Curasan AG Latest Developments
Table 115. Meril Life Sciences Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 116. Meril Life Sciences Absorbable Hemostat Product Portfolios and Specifications
Table 117. Meril Life Sciences Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Meril Life Sciences Main Business
Table 119. Meril Life Sciences Latest Developments
Table 120. Zhonghui Shengxi Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 121. Zhonghui Shengxi Absorbable Hemostat Product Portfolios and Specifications
Table 122. Zhonghui Shengxi Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Zhonghui Shengxi Main Business
Table 124. Zhonghui Shengxi Latest Developments
Table 125. Beijing Datsing Bio-tech Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 126. Beijing Datsing Bio-tech Absorbable Hemostat Product Portfolios and Specifications
Table 127. Beijing Datsing Bio-tech Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Beijing Datsing Bio-tech Main Business
Table 129. Beijing Datsing Bio-tech Latest Developments
Table 130. Guizhou Jin Jiu Biotech Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 131. Guizhou Jin Jiu Biotech Absorbable Hemostat Product Portfolios and Specifications
Table 132. Guizhou Jin Jiu Biotech Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Guizhou Jin Jiu Biotech Main Business
Table 134. Guizhou Jin Jiu Biotech Latest Developments
Table 135. Beijing Taikesiman Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 136. Beijing Taikesiman Absorbable Hemostat Product Portfolios and Specifications
Table 137. Beijing Taikesiman Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Beijing Taikesiman Main Business
Table 139. Beijing Taikesiman Latest Developments
Table 140. Foryou Medical Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 141. Foryou Medical Absorbable Hemostat Product Portfolios and Specifications
Table 142. Foryou Medical Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Foryou Medical Main Business
Table 144. Foryou Medical Latest Developments
Table 145. Saikesaisi Holdings Group Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 146. Saikesaisi Holdings Group Absorbable Hemostat Product Portfolios and Specifications
Table 147. Saikesaisi Holdings Group Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Saikesaisi Holdings Group Main Business
Table 149. Saikesaisi Holdings Group Latest Developments
Table 150. Biotemed Basic Information, Absorbable Hemostat Manufacturing Base, Sales Area and Its Competitors
Table 151. Biotemed Absorbable Hemostat Product Portfolios and Specifications
Table 152. Biotemed Absorbable Hemostat Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Biotemed Main Business
Table 154. Biotemed Latest Developments

Logo

Global Absorbable Hemostat Market Growth 2024-2030

Contact usWe are friendly and approachable, give us a call.